EODData

OTCBB, JBPHF: Jacobio Pharmaceuticals Group CO Ltd

23 Jan 2026
LAST:

0.8647

CHANGE:
 0.03
OPEN:
0.8647
HIGH:
0.8647
ASK:
0.0000
VOLUME:
100
CHG(%):
3.98
PREV:
0.8316
LOW:
0.8647
BID:
0.0000
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
23 Jan 260.86470.86470.86470.8647100

PROFILE

Name:Jacobio Pharmaceuticals Group CO Ltd
About:Jacobio Pharmaceuticals Group Co., Ltd., an investment holding company, engages in the in-house discovery and development of oncology therapies. Its clinical stage candidates include Glecirasib (JAB-21822), a KRAS G12C inhibitor under various stage studies for indications, such as NSCLC, PDAC, CRC, and other solid tumors; Sitneprotafib (JAB-3312), an SHP2 inhibitor that is in Phase III trials for NSCLC indication; JAB-23E73, a Pan-KRAS inhibitor for indications, including PDAC, CRC, and NSCLC; JAB-2485 Aurora A inhibitor, JAB-30355 p53 Y220C reactivator, JAB-BX102 CD73 mAb inhibitor, JAB-26766 PARP 7 inhibitor, and JAB-BX300 LIF inhibitor under trials for solid tumor indications; and JAB-24114, a glutamine-utilizing enzyme for solid tumors and hematological malignancies. The company also develops IND-enabling candidates comprising JAB-BX467, JAB-BX600, and JAB-BX700 for solid tumor indications. The company has a collaboration agreement with Merck for combination trials of cetuximab. Jacobio Pharmaceuticals Group Co., Ltd. was founded in 2015 and is headquartered in Beijing, China.
Sector:Healthcare
Industry:Biotechnology
Address:Building 8, Beijing, China
Website:https://www.jacobiopharma.com
FIGI:BBG016PJFDQ3

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:0.948.6%
Week High:0.860.0%
Week Low:0.860.0%